Immune toxicity in post autologous transplant patients treated with brentuximab vedotin in combination with immune checkpoint blockade. Diefenbach, C., Hong, F., Ambinder, R. F., Cohen, J., David, K., Advani, R. H., Robertson, M. J., Fenske, T. S., Barta, S. K., Palmisano, N., Svoboda, J., Morgan, D. S., Karmali, R., Kahl, B., Ansell, S. M. AMER SOC CLINICAL ONCOLOGY. 2018

View details for Web of Science ID 000442916003027